Several studies support, both in vitro and in vivo, the anti-cancer effects of cannabidiol
(CBD), a transient receptor potential vanilloid 2 (TRPV2) ligand. TRPV2, often dysregulated …

Among a variety of phytocannabinoids, Δ 9-tetrahydrocannabinol (THC) and cannabidiol
(CBD) are the most promising therapeutic compounds. Besides the well-known palliative …

Colon cancer is the third most common human malignancy and a main cause of death
worldwide. The current study was carried out to investigate the effects of cannabidiol, a …

Limited therapeutic interventions are clinically available for treating aggressive endometrial
cancer (EC). Therefore, effective therapies are urgently required. Therefore, the present …

Prostate cancer is the second most frequent cancer diagnosed in men in the world today.
Almost all prostate cancers are adenocarcinomas and develop from gland cells. We used …

Simple Summary Drug resistance is the key factor contributing to the therapeutic failure of
lung cancer and the deaths related to lung cancer. Our study demonstrated that small …

Cannabidiol (CBD), a nonpsychoactive phytocannabinoid, has recently emerged as a
potential cytotoxic agent in addition to its ameliorative activity in chemotherapy-associated …

Colorectal cancer (CRC) is the leading cause of cancer deaths worldwide, wherein distant
metastasis is the main reason for death. The non-psychoactive phytocannabinoid …

The main chemical component of cannabis, cannabidiol (CBD), has been shown to have
antitumor properties. The present study examined the in vitro effects of CBD on human …

The anti-tumor role and mechanisms of Cannabidiol (CBD), a non-psychotropic cannabinoid
compound, are not well studied especially in triple-negative breast cancer (TNBC). In the …